<DOC>
	<DOCNO>NCT02204891</DOCNO>
	<brief_summary>The aim present study demonstrate effect mixture four specie probiotic ( Saccharomyces boulardii , Bifidobacterium lactis BB-12 , Lactobacillus acidophilus LA-5 Lactobacillus plantarum ) patient symptomatic irritable bowel syndrome ( IBS ) culture verify syndrome intestinal bacterial overgrowth ( SIBO ) . This provide direct evidence role probiotic treat part pathogenesis IBS .</brief_summary>
	<brief_title>Probiotics Intestinal Bacterial Overgrowth</brief_title>
	<detailed_description>Irritable bowel syndrome ( IBS ) common gastrointestinal disorder . Pathogenesis remain multifactorial . Better understanding interaction host intestinal microbiota last decade lead knowledge many symptom IBS , mainly bloat diarrhea , related overgrowth bacteria colonic type small intestine . This overgrowth frame syndrome intestinal bacterial overgrowth ( SIBO ) colonic type bacteria predominate proximal part small intestine . Fermentation dietary carbohydrate bacteria colonizer SIBO end over-production gas generate thus symptom IBS . The relationship IBS SIBO find series prospective observational study use lactulose glucose tolerance test diagnosis SIBO . Using test , prevalence SIBO patient IBS range 65 85 % . The gold-standard technique diagnosis SIBO quantitative culture content proximal intestine i.e . duodenum upper GI tract endoscopy . Few study available design suggest growth colonic type flora count equal great 10^5 cfu/ml diagnostic SIBO . Based systematic review literature also data generate cohort 320 consecutive patient undergo upper GI tract endoscopy , normal subject never great 10^3 cfu/m duodenum . In latter publication come Athens , use variable cut-offs great 10^3 10^4 10^5 cfu/ml diagnosis SIBO , frequency SIBO significantly great among sufferer among non-sufferers IBS . Oral supplementation probiotic may rational approach eradication SIBO subsequently symptoms IBS . The majority probiotic bacteria belong Lactobacillus Bifidobacterium genus . They Gram-positive lactic acid-producing bacteria constitute major part normal intestinal microflora animal human . The rationale behind use therapeutic strategy IBS orally administer probiotic may replace overgrown enteric-type bacteria SIBO . Four randomized clinical trial available evaluate efficacy orally administer probiotic IBS . The common finding trial ) efficacy refers improvement symptom bloat diarrhea typical symptom presence SIBO ; b ) efficacy usually find mixture different specie probiotic use . However , study ever test efficacy probiotic patient IBS SIBO proven small intestinal culture . The aim present study demonstrate effect mixture four specie probiotic ( Saccharomyces boulardii , Bifidobacterium lactis BB-12 , Lactobacillus acidophilus LA-5 Lactobacillus plantarum ) patient symptomatic IBS culture verify SIBO . This provide direct evidence role probiotic treat part pathogenesis IBS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>1 . Age â‰¥18 year 2 . Both gender 3 . Written inform consent study participant 4 . Presence IBS accord Rome III criteria 5 . Equal number SIBOpositive SIBOnegative patient 1 . Age &lt; 18 year 2 . Deny consent 3 . Pregnancy lactation 4 . Presence inflammatory bowel disease 5 . Presence acute GI tract infection 6 . Diabetes mellitus type 1 type 2 7 . Use laxatives antibiotic within precede 6 week 8 . Presence fever , abdominal mass , sign bowel obstruction and/or leucocytosis 9 . Abnormal serum level thyroid stimulate hormone . 10 . History colon cancer diverticulitis 11 . Infection human immunodeficiency virus ( HIV ) , hepatitis B virus hepatitis C virus 12 . Patients celiac disease define biopsy duodenal mucosa . 13 . History scleroderma gastroparesis 14 . Pregnancy plan pregnancy next 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Abdominal pain</keyword>
	<keyword>Abdominal discomfort</keyword>
	<keyword>Flatulence</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Bacterial overgrowth</keyword>
	<keyword>Cytokines</keyword>
</DOC>